Abstract
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have